Replies to post #675 on BioMarin Pharmaceutical Inc. (BMRN)

[MedResCollab]

Experiments in juveniles and infants can garner public praise, lower regulatory hurdles, and mask overspending. It creates a unique and problematic bias. In the US, mores are well established in this regard. One cannot question the utility of such treatments without being vilified.